Stay updated on Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial
Sign up to get notified when there's something new on the Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial page.

Latest updates to the Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe NIH banner announcing terminology changes and related updates is no longer displayed.SummaryDifference1%

- Check20 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedA site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference1%

- Check34 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2; the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content. The visible addition indicates access to the study record is blocked, while site chrome remains, signaling a restricted access state.SummaryDifference18%

Stay in the know with updates to Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial page.